Tuyển tập các báo cáo nghiên cứu khoa học ngành y học tạp chí Medical Sciences dành cho các bạn sinh viên ngành y tham khảo đề tài: Management of Critically Ill Patients with Severe Acute Respiratory Syndrome (SARS). | Int. J. Med. Sci. 2004 1 1 1-10 1 International Journal of Medical Sciences ISSN 1449-1907 2004 1 1 1-10 2004 Ivyspring International Publisher. All rights reserved Review Received Accepted Published Abstract Key words Author biography Corresponding address Management of Critically Ill Patients with Severe Acute Respiratory Syndrome SARS Arthur Chun-Wing LAU Loretta Yin-Chun YAM Loletta Kit-Ying SO Division of Respiratory and Critical Care Medicine Department of Medicine Pamela Youde Nethersole Eastern Hospital Hong Kong SAR PR China Severe acute respiratory syndrome SARS is frequently complicated with acute respiratory failure. In this article we aim to focus on the management of the subgroup of SARS patients who are critically ill. Most SARS patients would require high flow oxygen supplementation 20-30 required intensive care unit ICU or high dependency care and 13-26 developed acute respiratory distress syndrome ARDS . In some of these patients the clinical course can progress relentlessly to septic shock and or multiple organ dysfunction syndrome MODS . The management of critically ill SARS patients requires timely institution of pharmacotherapy where applicable and supportive treatment oxygen therapy noninvasive and invasive ventilation . Superimposed bacterial and other opportunistic infections are common especially in those treated with mechanical ventilation. Subcutaneous emphysema pneumothoraces and pneumomediastinum may arise spontaneously or as a result of positive ventilatory assistance. Older age is a consistently a poor prognostic factor. Appropriate use of personal protection equipment and adherence to infection control measures is mandatory for effective infection control. Much of the knowledge about the clinical aspects of SARS is based on retrospective observational data and randomized-controlled trials are required for confirmation. Physicians and scientists all over the world should collaborate to .
